Percheron Therapeutics Limited (ASX:PER)
0.0050
+0.0005 (11.11%)
Jun 19, 2026, 4:10 PM AEST
Percheron Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 4.46 | 10.17 | 11.87 | 10.97 | 19.23 | 6.02 |
Cash & Short-Term Investments | 4.46 | 10.17 | 11.87 | 10.97 | 19.23 | 6.02 |
Cash Growth | -74.37% | -14.32% | 8.20% | -42.98% | 219.47% | 48.31% |
Accounts Receivable | 0.1 | 0.06 | 0.08 | 0.03 | 0.03 | 0.01 |
Other Receivables | - | 1.52 | 2.48 | 1.63 | 1.81 | 0.59 |
Receivables | 0.1 | 1.58 | 2.57 | 1.66 | 1.84 | 0.6 |
Prepaid Expenses | 0.25 | 0.65 | 0.04 | 0.07 | 0.61 | 0.08 |
Other Current Assets | - | - | - | - | 0.53 | - |
Total Current Assets | 4.8 | 12.4 | 14.47 | 12.69 | 22.22 | 6.7 |
Property, Plant & Equipment | 0.02 | 0.04 | 0.06 | 0.15 | 0.22 | 0.3 |
Total Assets | 7.9 | 12.44 | 14.53 | 12.84 | 22.44 | 7 |
Accounts Payable | 0.58 | 1.43 | 3.73 | 1.02 | 0.33 | 0.16 |
Accrued Expenses | 0.17 | 0.16 | 0.25 | 1.69 | 0.73 | 0.8 |
Current Portion of Leases | 0.01 | 0.03 | 0.04 | 0.09 | 0.09 | 0.08 |
Other Current Liabilities | - | 0.81 | 1.14 | 0 | 0 | 0 |
Total Current Liabilities | 0.76 | 2.43 | 5.15 | 2.81 | 1.16 | 1.05 |
Long-Term Leases | - | - | - | 0.05 | 0.13 | 0.23 |
Other Long-Term Liabilities | - | - | 0.02 | 0.01 | 0 | 0 |
Total Liabilities | 0.76 | 2.43 | 5.17 | 2.87 | 1.3 | 1.27 |
Common Stock | 112.05 | 112.05 | 109.37 | 98.26 | 98.13 | 77.03 |
Retained Earnings | -106.77 | -103.67 | -101.73 | -92.29 | -80.91 | -75.1 |
Comprehensive Income & Other | 1.86 | 1.62 | 1.72 | 4 | 3.92 | 3.79 |
Shareholders' Equity | 7.14 | 10 | 9.36 | 9.98 | 21.14 | 5.73 |
Total Liabilities & Equity | 7.9 | 12.44 | 14.53 | 12.84 | 22.44 | 7 |
Total Debt | 0.01 | 0.03 | 0.04 | 0.14 | 0.23 | 0.31 |
Net Cash (Debt) | 4.45 | 10.14 | 11.83 | 10.83 | 19.01 | 5.71 |
Net Cash Growth | -74.33% | -14.25% | 9.25% | -43.04% | 232.64% | 45.60% |
Net Cash Per Share | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | 0.01 |
Filing Date Shares Outstanding | 1,087 | 1,087 | 901.54 | 836.3 | 668.79 | 574.48 |
Total Common Shares Outstanding | 1,087 | 1,087 | 901.54 | 669.31 | 668.79 | 574.48 |
Working Capital | 4.04 | 9.97 | 9.32 | 9.88 | 21.06 | 5.65 |
Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 |
Tangible Book Value | 4.06 | 10 | 9.36 | 9.98 | 21.14 | 5.73 |
Tangible Book Value Per Share | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 |